NCT05092152View on ClinicalTrials.gov

Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

October 23, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Acute Respiratory Failure
Interventions
DRUG

Esketamine

2 mg per kilogram of body weight

DRUG

Propofol

1.5 mg per kilogram of body weight

Trial Locations (1)

04038002

Federal University of São Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT05092152 - Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients | Biotech Hunter | Biotech Hunter